Modified Fluoroquinolones as Antimicrobial Compounds Targeting Chlamydia trachomatis

Area of Science:

• Medicinal Chemistry
• Antimicrobial Drug Discovery
• Infectious Diseases

Background:

• Chlamydia trachomatis is a major cause of bacterial sexually transmitted infections and trachoma, leading to infertility and blindness.
• Current treatments face challenges, necessitating the development of novel therapeutic strategies.
• Previous work enhanced fluoroquinolone activity against C. trachomatis via metal chelating moiety grafting.

Purpose of the Study:

• To further explore pharmacomodulation of fluoroquinolones to enhance antichlamydial activity.
• To synthesize and evaluate novel molecules with improved efficacy against C. trachomatis.
• To assess the broader antibacterial spectrum of these novel compounds against other pathogens.

Main Methods:

• Pharmacomodulation of ciprofloxacin by grafting a metal chelating moiety.
• Synthesis of novel fluoroquinolone derivatives.
• Evaluation of antichlamydial activity using EC₅₀ values and testing against Neisseria gonorrhoeae and ESKAPE pathogens.

Main Results:

• Novel molecules achieved nanomolar activity (EC₅₀) against Chlamydia trachomatis.
• The enhanced molecules demonstrated selective activity against C. trachomatis.
• Activity against Neisseria gonorrhoeae and ESKAPE group bacteria was also evaluated.

Conclusions:

• Pharmacomodulation successfully enhanced the antichlamydial effect of fluoroquinolones.
• The developed molecules show significant promise for treating C. trachomatis infections.
• This strategy highlights a viable approach for improving fluoroquinolone-based antimicrobials.